Table 2.
Multivariable logistic regression of secondary outcome
Characteristic | ORA | 95% CIB | p-value |
---|---|---|---|
Age | 0.96 | 0.95,0.97 | <0.001 |
Male Sex | 1.35 | 1.18,1.55 | <0.001 |
BMI | 0.98 | 0.97,0.99 | 0.001 |
HbA1c | 1.27 | 1.21,1.34 | <0.001 |
Use of Insulins | 1.38 | 1.18,1.61 | <0.001 |
Use of GLP-1 Agonists | 2.45 | 2.09,2.86 | <0.001 |
Use of DPP-4 Inhibitors | 1.82 | 1.54,2.15 | <0.001 |
Use of Biguanides | 1.67 | 1.45,1.93 | <0.001 |
Use of Sulfonylureas | 1.83 | 1.59,2.11 | <0.001 |
Use of Thiazolidinediones | 1.40 | 1.07,1.82 | 0.013 |
Concomitant Heart Disease | 1.33 | 1.15,1.54 | <0.001 |
Concomitant Heart Failure | 1.76 | 1.49,2.07 | <0.001 |
OR = Odds Ratio,
CI = Confidence Interval
BMI: body mass index
HbA1c: hemoglobin A1c
GLP-1: glucagon-like peptide-1
DPP-4: dipeptidyl peptidase-4